Results
1 -
7 of
7
(Click
here to explore results)
- Review on anti-alzheimer drug development: approaches, challenges and perspectives. Abdallah E. Abdallah
, RSC Adv.
, 2024
, 14
, 11057
- A study of protein–drug interaction based on solvent-induced protein aggregation by fluorescence correlation spectroscopy. Caining Xue, Wenxin Yu, Haohan Song, Xiangyi Huang, Jicun Ren
, Analyst
, 2022
, 147
, 1357
- Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis. Sujan Kalita, Sourav Kalita, Altaf Hussain Kawa, Sukesh Shill, Anjali Gupta, Sachin Kumar, Bhubaneswar Mandal
, RSC Med. Chem.
, 2022
, 13
, 761
- Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease. K. Rajasekhar, Malabika Chakrabarti, T. Govindaraju
, Chem. Commun.
, 2015
, 51
, 13434
- Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. Jonathan D. Low, Michael D. Bartberger, Kui Chen, Yuan Cheng, Mark R. Fielden, Vijay Gore, Dean Hickman, Qingyian Liu, E. Allen Sickmier, Hugo M. Vargas, Jonathan Werner, Ryan D. White, Douglas A. Whittington, Stephen Wood, Ana E. Minatti
, Med. Chem. Commun.
, 2017
, 8
, 1196
- Two decades of new drug discovery and development for Alzheimer's disease. Zhidong Liu, Aihua Zhang, Hui Sun, Ying Han, Ling Kong, Xijun Wang
, RSC Adv.
, 2017
, 7
, 6046
- Synthesis of amino heterocycle aspartyl protease inhibitors. Rachel K. Chambers, Tanweer A. Khan, David B. Olsen, Brad E. Sleebs
, Org. Biomol. Chem.
, 2016
, 14
, 4970